Market Share of Global Diabetic Retinopathy Industry
The Diabetic Retinopathy market is moderately competitive and consists of a few major players. Companies like Alimera Sciences, Allergan plc, BCN Peptides, F. Hoffmann-La Roche Ltd, Glycadia Pharmaceuticals, Kowa Group, Novartis AG, and Oxurion NV. The players are adopting strategies such as partnerships and acquisitions, product launches, research and development activities, and rising investments to strengthen their presence in the market.
Diabetic Retinopathy Market Leaders
Regeneron Pharmaceuticals, Inc.
Alimera Sciences
Oxurion NV.
Abbvie Inc.
F. Hoffmann-La Roche Ltd
*Disclaimer: Major Players sorted in no particular order
